Compare SELF & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SELF | VNRX |
|---|---|---|
| Founded | 1983 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.0M | 24.5M |
| IPO Year | 1997 | 2012 |
| Metric | SELF | VNRX |
|---|---|---|
| Price | $5.25 | $1.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $6.00 | $1.67 |
| AVG Volume (30 Days) | 15.1K | ★ 318.7K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | ★ 5.25% | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $12,705,245.00 | $1,727,384.00 |
| Revenue This Year | $3.04 | $355.66 |
| Revenue Next Year | $3.47 | $849.08 |
| P/E Ratio | $130.50 | ★ N/A |
| Revenue Growth | 1.40 | ★ 40.04 |
| 52 Week Low | $4.73 | $0.13 |
| 52 Week High | $5.63 | $3.26 |
| Indicator | SELF | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.98 | 43.91 |
| Support Level | $4.96 | $1.30 |
| Resistance Level | $5.27 | $1.56 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 53.57 | 62.82 |
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.